Indivumed appoints Harald Eistetter as Chief Business Officer and Managing Director
Indivumed GmbH announced the appointment of Harald R Eistetter, PhD, as Managing Director and to the newly created position of Chief Business Officer.
Dr Eistetter, who has more than two decades of leadership experience in the pharmaceutical and biotech industry, will be responsible in particular for further developing and implementing Indivumed's corporate strategy and commercial potential. He joins from The Genetics Company Inc., a Zurich, Switzerland, based drug and diagnostics discovery company, where he served as Chief Executive Officer for the past six years. Dr. Eistetter started his professional career with Altana Pharma and subsequently held several senior and international management positions within Glaxo and BASF Pharma. His interests are in the fields of oncology and neuroscience and he received his PhD in Genetics from the University of Tuebingen, Germany in 1985.
Other news from the department people
